| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Division of Cell Biology, Wellcome Research Laboratories, Research Triangle Park, North Carolina 27709
A plasmid containing the CCAAT/enhancer-binding protein (C/EBP
) gene transcriptionally controlled by the metallothionein promoter was constructed. The gene was transfected into the human hepatocellular carcinoma cell lines Hep3B and HepG2. When cultured in vitro in the presence of 100 µM ZnSO4, C/EBP
expression caused reversible growth arrest. In soft agar clonogenic assays, C/EBP
expression decreased both the colony size and the total number of colonies compared with zinc-free controls. C/EBP
expressing cells s.c. implanted in Cd-1 nu/nu mice were essentially nontumorigenic, whereas C/EBP
tumor cells implanted into immunodeficient SCID mice demonstrated a significantly delayed time of tumor appearance compared with cells transfected with a vector control plasmid. These studies suggest that the expression of endogenous genes normally associated with a quiescent, differentiated state, such as C/EBP
, can result in impaired proliferative activity and suppressed tumorigenicity of hepatoma cell lines.
1 To whom reprint requests should be addressed, at Division of Cell Biology, Wellcome Research Laboratories, 3030 Cornwallis Road, Research Triangle Park, NC 27709. Phone: (919)-483-1262; Fax: (919)-315-3321.
Received 6/27/95. Accepted 1/ 2/96.
This article has been cited by other articles:
![]() |
T. Pabst and B. U. Mueller Complexity of CEBPA Dysregulation in Human Acute Myeloid Leukemia Clin. Cancer Res., September 1, 2009; 15(17): 5303 - 5307. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Koschmieder, B. Halmos, E. Levantini, and D. G. Tenen Dysregulation of the C/EBP{alpha} Differentiation Pathway in Human Cancer J. Clin. Oncol., February 1, 2009; 27(4): 619 - 628. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Loomis, S. Zhu, K. Yoon, P. F. Johnson, and R. C. Smart Genetic Ablation of CCAAT/Enhancer Binding Protein {alpha} in Epidermis Reveals Its Role in Suppression of Epithelial Tumorigenesis Cancer Res., July 15, 2007; 67(14): 6768 - 6776. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Parent, D. Kolippakkam, G. Booth, and L. Beretta Mammalian Target of Rapamycin Activation Impairs Hepatocytic Differentiation and Targets Genes Moderating Lipid Homeostasis and Hepatocellular Growth Cancer Res., May 1, 2007; 67(9): 4337 - 4345. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yin and J. Glass In Prostate Cancer Cells the Interaction of C/EBP{alpha} with Ku70, Ku80, and Poly(ADP-ribose) Polymerase-1 Increases Sensitivity to DNA Damage J. Biol. Chem., April 28, 2006; 281(17): 11496 - 11505. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tada, R. M. Brena, B. Hackanson, C. Morrison, G. A. Otterson, and C. Plass Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer. J Natl Cancer Inst, March 15, 2006; 98(6): 396 - 406. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shim, K. L. Powers, S. J. Ewing, S. Zhu, and R. C. Smart Diminished Expression of C/EBP{alpha} in Skin Carcinomas Is Linked to Oncogenic Ras and Reexpression of C/EBP{alpha} in Carcinoma Cells Inhibits Proliferation Cancer Res., February 1, 2005; 65(3): 861 - 867. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Halmos, D. S. Basseres, S. Monti, F. D'Alo, T. Dayaram, K. Ferenczi, B. J. Wouters, C. S. Huettner, T. R. Golub, and D. G. Tenen A Transcriptional Profiling Study of CCAAT/Enhancer Binding Protein Targets Identifies Hepatocyte Nuclear Factor 3{beta} as a Novel Tumor Suppressor in Lung Cancer Cancer Res., June 15, 2004; 64(12): 4137 - 4147. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. D'Alo', L. M. Johansen, E. A. Nelson, H. S. Radomska, E. K. Evans, P. Zhang, C. Nerlov, and D. G. Tenen The amino terminal and E2F interaction domains are critical for C/EBP{alpha}-mediated induction of granulopoietic development of hematopoietic cells Blood, November 1, 2003; 102(9): 3163 - 3171. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Bjerregaard, J. Jurlander, P. Klausen, N. Borregaard, and J. B. Cowland The in vivo profile of transcription factors during neutrophil differentiation in human bone marrow Blood, June 1, 2003; 101(11): 4322 - 4332. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Iwama, M. Osawa, R. Hirasawa, N. Uchiyama, S. Kaneko, M. Onodera, K. Shibuya, A. Shibuya, C. Vinson, D. G. Tenen, et al. Reciprocal Roles for CCAAT/Enhancer Binding Protein (C/EBP) and PU.1 Transcription Factors in Langerhans Cell Commitment J. Exp. Med., February 25, 2002; 195(5): 547 - 558. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Gombart, W.-K. Hofmann, S. Kawano, S. Takeuchi, U. Krug, S. H. Kwok, R. J. Larsen, H. Asou, C. W. Miller, D. Hoelzer, et al. Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein alpha in myelodysplastic syndromes and acute myeloid leukemias Blood, February 15, 2002; 99(4): 1332 - 1340. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Halmos, C. S. Huettner, O. Kocher, K. Ferenczi, D. D. Karp, and D. G. Tenen Down-Regulation and Antiproliferative Role of C/EBP{alpha} in Lung Cancer Cancer Res., January 1, 2002; 62(2): 528 - 534. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Johansen, A. Iwama, T. A. Lodie, K. Sasaki, D. W. Felsher, T. R. Golub, and D. G. Tenen c-Myc Is a Critical Target for C/EBP{alpha} in Granulopoiesis Mol. Cell. Biol., June 1, 2001; 21(11): 3789 - 3806. [Abstract] [Full Text] |
||||
![]() |
L. Xu, L. Hui, S. Wang, J. Gong, Y. Jin, Y. Wang, Y. Ji, X. Wu, Z. Han, and G. Hu Expression Profiling Suggested a Regulatory Role of Liver-enriched Transcription Factors in Human Hepatocellular Carcinoma Cancer Res., April 1, 2001; 61(7): 3176 - 3181. [Abstract] [Full Text] |
||||
![]() |
P. Zhang, X. Zhang, A. Iwama, C. Yu, K. A. Smith, B. U. Mueller, S. Narravula, B. E. Torbett, S. H. Orkin, and D. G. Tenen PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding Blood, October 15, 2000; 96(8): 2641 - 2648. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Slomiany, K. L. D'Arigo, M. M. Kelly, and D. T. Kurtz C/EBPalpha Inhibits Cell Growth via Direct Repression of E2F-DP-Mediated Transcription Mol. Cell. Biol., August 15, 2000; 20(16): 5986 - 5997. [Abstract] [Full Text] |
||||
![]() |
S. Kubicka, F. Kuhnel, L. Zender, K. L. Rudolph, J. Plumpe, M. Manns, and C. Trautwein p53 Represses CAAT Enhancer-binding Protein (C/EBP)-dependent Transcription of the Albumin Gene. A MOLECULAR MECHANISM INVOLVED IN VIRAL LIVER INFECTION WITH IMPLICATIONS FOR HEPATOCARCINOGENESIS J. Biol. Chem., November 5, 1999; 274(45): 32137 - 32144. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Ramos, W. J. Meilandt, E. C. Wang, and G. L. Firestone Dysfunctional glucocorticoid receptor with a single point mutation ablates the CCAAT/enhancer binding protein-dependent growth suppression response in a steroid-resistant rat hepatoma cell variant FASEB J, January 1, 1999; 13(1): 169 - 180. [Abstract] [Full Text] |
||||
![]() |
A. M. Diehl Roles of CCAAT/Enhancer-binding Proteins in Regulation of Liver Regenerative Growth J. Biol. Chem., November 20, 1998; 273(47): 30843 - 30846. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kim and S. M. Fischer Transcriptional Regulation of Cyclooxygenase-2 in Mouse Skin Carcinoma Cells. REGULATORY ROLE OF CCAAT/ENHANCER-BINDING PROTEINS IN THE DIFFERENTIAL EXPRESSION OF CYCLOOXYGENASE-2 IN NORMAL AND NEOPLASTIC TISSUES J. Biol. Chem., October 16, 1998; 273(42): 27686 - 27694. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Radomska, C. S. Huettner, P. Zhang, T. Cheng, D. T. Scadden, and D. G. Tenen CCAAT/Enhancer Binding Protein alpha Is a Regulatory Switch Sufficient for Induction of Granulocytic Development from Bipotential Myeloid Progenitors Mol. Cell. Biol., July 1, 1998; 18(7): 4301 - 4314. [Abstract] [Full Text] |
||||
![]() |
D. G. Tenen, R. Hromas, J. D. Licht, and D.-E. Zhang Transcription Factors, Normal Myeloid Development, and Leukemia Blood, July 15, 1997; 90(2): 489 - 519. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |